These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 18958369)
1. HSV gene transfer in the treatment of chronic pain. Fink DJ; Mata M Sheng Li Xue Bao; 2008 Oct; 60(5):610-6. PubMed ID: 18958369 [TBL] [Abstract][Full Text] [Related]
2. Development of HSV-mediated gene transfer for the treatment of chronic pain. Mata M; Glorioso J; Fink DJ Exp Neurol; 2003 Nov; 184 Suppl 1():S25-9. PubMed ID: 14597322 [TBL] [Abstract][Full Text] [Related]
3. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats. Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180 [TBL] [Abstract][Full Text] [Related]
4. Vector-mediated gene transfer to express inhibitory neurotransmitters in dorsal root ganglion reduces pain in a rodent model of lumbar radiculopathy. Lee JY; Fink DJ; Mata M Spine (Phila Pa 1976); 2006 Jun; 31(14):1555-8. PubMed ID: 16778687 [TBL] [Abstract][Full Text] [Related]
5. Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors. Glorioso JC; Mata M; Fink DJ Expert Opin Biol Ther; 2003 Dec; 3(8):1233-9. PubMed ID: 14640949 [TBL] [Abstract][Full Text] [Related]
6. Herpes simplex viral and amplicon vector-mediated gene transfer into glia and neurons in organotypic spinal cord and dorsal root ganglion cultures. Marsh DR; Dekaban GA; Tan W; Strathdee CA; Weaver LC Mol Ther; 2000 May; 1(5 Pt 1):464-78. PubMed ID: 10933968 [TBL] [Abstract][Full Text] [Related]
7. A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Wolfe D; Mata M; Fink DJ Gene Ther; 2009 Apr; 16(4):455-60. PubMed ID: 19242524 [TBL] [Abstract][Full Text] [Related]
8. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Glorioso JC; Fink DJ Annu Rev Microbiol; 2004; 58():253-71. PubMed ID: 15487938 [TBL] [Abstract][Full Text] [Related]
9. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Wolfe D; Hao S; Hu J; Srinivasan R; Goss J; Mata M; Fink DJ; Glorioso JC Pain; 2007 Dec; 133(1-3):29-38. PubMed ID: 17395375 [TBL] [Abstract][Full Text] [Related]
10. In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Chattopadhyay M; Wolfe D; Huang S; Goss J; Glorioso JC; Mata M; Fink DJ Ann Neurol; 2002 Jan; 51(1):19-27. PubMed ID: 11782980 [TBL] [Abstract][Full Text] [Related]
12. Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents. Smith SN; Paige C; Velazquez KT; Smith TP; Raja SN; Wilson SP; Sweitzer SM J Pain; 2015 Mar; 16(3):283-90. PubMed ID: 25576797 [TBL] [Abstract][Full Text] [Related]
13. Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury. Shimizu N; Doyal MF; Goins WF; Kadekawa K; Wada N; Kanai AJ; de Groat WC; Hirayama A; Uemura H; Glorioso JC; Yoshimura N Neuroscience; 2017 Nov; 364():190-201. PubMed ID: 28942324 [TBL] [Abstract][Full Text] [Related]
14. Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Hao S; Mata M; Wolfe D; Huang S; Glorioso JC; Fink DJ Ann Neurol; 2005 Jun; 57(6):914-8. PubMed ID: 15929041 [TBL] [Abstract][Full Text] [Related]
15. HSV vector-mediated GAD67 suppresses neuropathic pain induced by perineural HIV gp120 in rats through inhibition of ROS and Wnt5a. Kanda H; Kanao M; Liu S; Yi H; Iida T; Levitt RC; Candiotti KA; Lubarsky DA; Hao S Gene Ther; 2016 Apr; 23(4):340-8. PubMed ID: 26752351 [TBL] [Abstract][Full Text] [Related]
16. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Liu J; Wolfe D; Hao S; Huang S; Glorioso JC; Mata M; Fink DJ Mol Ther; 2004 Jul; 10(1):57-66. PubMed ID: 15233942 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice. Ma F; Wang C; Yoder WE; Westlund KN; Carlson CR; Miller CS; Danaher RJ J Oral Facial Pain Headache; 2016; 30(1):42-50. PubMed ID: 26817032 [TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of growth factors by HSV-mediated gene transfer for peripheral neuropathy. Chattopadhyay M Curr Gene Ther; 2013 Oct; 13(5):315-21. PubMed ID: 24369058 [TBL] [Abstract][Full Text] [Related]
19. HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Hao S; Mata M; Wolfe D; Huang S; Glorioso JC; Fink DJ Mol Ther; 2003 Sep; 8(3):367-75. PubMed ID: 12946309 [TBL] [Abstract][Full Text] [Related]
20. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Yokoyama H; Sasaki K; Franks ME; Goins WF; Goss JR; de Groat WC; Glorioso JC; Chancellor MB; Yoshimura N Hum Gene Ther; 2009 Jan; 20(1):63-71. PubMed ID: 20377371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]